DG Capital Management (Massachusetts)’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
$3.88M Buy
23,230
+5,840
+34% +$988K 3.81% 2
2016
Q2
$2.65M Buy
17,390
+2,060
+13% +$320K 2.82% 8
2016
Q1
$2.3M Sell
15,330
-10,910
-42% -$1.62M 2.25% 13
2015
Q4
$4.26M Sell
26,240
-9,445
-26% -$1.48M 3.8% 4
2015
Q3
$4.94M Buy
35,685
+5,400
+18% +$851K 3.32% 6
2015
Q2
$4.65M Sell
30,285
-15,108
-33% -$2.42M 2.8% 4
2015
Q1
$7.26M Sell
45,393
-1,665
-4% -$262K 4.37% 2
2014
Q4
$7.5M Sell
47,058
-9,090
-16% -$1.42M 4.34% 2
2014
Q3
$7.89M Buy
56,148
+7,518
+15% +$982K 4.81% 2
2014
Q2
$5.76M Sell
48,630
-20,580
-30% -$2.38M 3.28% 3
2014
Q1
$8.54M Buy
69,210
+17,450
+34% +$2.12M 5.05% 1
2013
Q4
$5.91M Buy
51,760
+9,440
+22% +$1.07M 3.29% 3
2013
Q3
$4.74M Buy
42,320
+20,730
+96% +$2.25M 2.68% 3
2013
Q2
$2.13M Buy
+21,590
New +$2.24M 1.29% 47

Other funds holding AMGN

DG Capital Management (Massachusetts)'s AMGN Position: Q3 2016 in Review

DG Capital Management (Massachusetts) increased its Amgen (AMGN) stake by 34% in Q3 2016, buying an estimated $988K and bringing the position to 23,230 shares worth $3.88M. The position accounts for 3.81% of the portfolio, ranked #2.

DG Capital Management (Massachusetts) first reported a position in AMGN in Q2 2013 and has held it in 14 quarters since. The position peaked at $8.54M in Q1 2014. 1,517 funds tracked by Wall St. Rank hold AMGN as of Q3 2016.

  • DG Capital Management (Massachusetts) held 23,230 shares of Amgen worth $3.88M as of Q3 2016.
  • DG Capital Management (Massachusetts) bought 5,840 Amgen shares in Q3 2016, an estimated $988K.
  • Amgen made up 3.81% of DG Capital Management (Massachusetts)'s portfolio in Q3 2016, its #2 holding.
  • DG Capital Management (Massachusetts) first reported a position in Amgen in Q2 2013 and has held it in 14 quarters since.
  • DG Capital Management (Massachusetts)'s Amgen position peaked at $8.54M in Q1 2014.
  • 1,517 funds tracked by Wall St. Rank held Amgen as of Q3 2016.

Based on DG Capital Management (Massachusetts)'s 13F filing for Q3 2016, filed 21 Oct 2016.